reduce insulin dose when starting glp-1 receptor agonist Agonists: An Alternative for Rapid-Acting Insulin? Glucagon-like peptide-1 receptor: mechanisms and
Description
Clinical effects of glucagon-like peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review

GLP-1s often lead to 3050 pounds of weight loss, while surgery can result in far greater total body weight reduction, particularly in those with a BMI over 40 or severe obesity-related health issues

Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al

Liraglutide and cardiovascular outcomes in type 2 diabetes
The platform is still building its reputation, so reviews are limited, but early patient feedback has been positive
